Answer
Severe hepatic impairment markedly increases ganaxolone exposure and requires a modified specialist plan and close clinical review.
Sources for this answer
- ZTALMY 50 mg/mL oral suspension — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.